跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZYPREXA VELOTAB 10 MG COMPRIMIDOS BUCODISPERSABLES - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ZYPREXA VELOTAB 10 MG COMPRIMIDOS BUCODISPERSABLES
Approved
STANDARD
ZYPREXA VELOTAB 10 MG COMPRIMIDOS BUCODISPERSABLES
Eli Lilly Nederland B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 21, 2023
Approval ID
48dd72a4f5bd62e1
Company
Eli Lilly Nederland B.V.
Type
Standard
Approval Details
Approval Id
48dd72a4f5bd62e1
Drug Cima Aemps Name
ZYPREXA VELOTAB 10 MG COMPRIMIDOS BUCODISPERSABLES
Register Number
99125006IP1
Holder Company Name
Eli Lilly Nederland B.V.
Marketing Company Name
Elam Pharma Labs S.L.
Holder Company Detail Path
/organization/eli-lilly-nederland-bv
Authorization Date
2023-09-21
Dosage Form
COMPRIMIDO BUCODISPERSABLE
Dose
10 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Eli Lilly Nederland B.V.
Company Detail Path
/organization/eli-lilly-nederland-bv
Company Information
Pharmaceutical Company Name
Eli Lilly Nederland BV
Country Name
Netherlands
Website
http://www.lilly.com/nl
Active Ingredients
OLANZAPINA
10 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 21, 2023
Approval ID
48dd72a4f5bd62e1
Type
Standard
Back to CIMA-AEMPS Approvals
